Marimed Stock News

MariMed Inc. (OTCQX:MRMD) Q1 2022 Earnings Conference Call May 11, 2022 8:00 AM ET Company Participants Steve West - Vice President of Investor Relations Bob Fireman - Chief Executive Officer Tim Shaw

NORWOOD, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today a

Cannabis Stocks: Near-Term Headwinds Don't Matter Much (Podcast Transcript)

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings and why disappointment is overblown.

NORWOOD, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today

Q4 results reflect continued strong execution on 2021 turnaround.

MariMed Inc.'s (MRMD) CEO Robert Fireman on Q4 2021 Results - Earnings Call Transcript

Top Penny Pot Stocks For Your List In MArch The post Taking Advantage Of Market Volatility? 3 Marijuana Penny Stocks To Watch In March appeared first on Marijuana Stocks | Cannabis Investments and New

MariMed, Inc. (OTCQX: MRMD ) launched Vibations: High + Energy, an all-natural, full-spectrum cannabis drink mix that provides focus and energy for the mind and body. This launch marks MariMed’s entry into cannabis-infused beverages , which, is one of the fastest-growing categories in the industry, according to Headset data. Active and athletic cannabis users have long desired an infused cannabis product that combines the focused mind with an energy boost. When mixed with water, Vibations: High + Energy provides that desired effect. “Like all MariMed products, we developed Vibations: High … Full story available on Benzinga.com

MariMed (MRMD) is acquiring a provisional dispensary license from Green House Naturals LLC.The dispensary will be in Beverly, a suburban City located on the north shore of the…

MariMed, Inc. (OTCQX: MRMD ) has signed a definitive agreement to acquire a provisional dispensary license from Green House Naturals, LLC. Deal Details The transaction, which is subject to customary closing conditions and regulatory approvals, will add a second retail location to MariMed’s vertically integrated cannabis operations in Massachusetts. Terms of the transaction were not disclosed. The assets of Green House Naturals to be acquired by MariMed include a provisional adult use dispensary license subject to approval of the Massachusetts Cannabis Control Commission, a Host Community Agreement to operate a dispensary from the City of Beverly, and the assignment of the leasehold approved for the business. The dispensary will be in Beverly, a … Full story available on Benzinga.com

The company signed a definitive agreement to acquire an adult-use dispensary license from Green House Naturals.

Echelon Capital Markets analyst Andrew Semple on Friday initiated coverage of Norwood, Mass.-based multi-state cannabis operator MariMed Inc. , which trades on the OTC. Semple rated the stock a speculative buy and set a 12-month target price of $1.50 a share for MariMed, which has grown cannabis revenue by more than seven times in the past two years. "We believe the management team are capable operators, as evidenced by the strong growth achieved in cannabis revenues, an impressive sales per store metric (annualized run rate of $18.8 million per store on average in Q321) and MariMed''s track record of having generated positive free cash flow in each of the past seven quarters," Semple said in a research note. MariMed, which has a market cap of about $246.5 million, has seen its stock fall by 13.3% in 2022, compared to a drop of 22.9% by the AdvisorShares Pure U.S. Cannabis ETF .The stock traded unchanged at 74 cents on Friday. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move.

Echelon Capital Markets analyst Andrew Semple on Friday initiated coverage of Norwood, Mass.-based multi-state cannabis operator MariMed Inc. MRMD, +1.32% , which trades on the OTC.

Marijuana penny stocks may rally violently if optimism returns to the cannabis industry. Think of a 1,687% gain under similar conditions.